Phio Pharmaceuticals Corp Share Price Today: Live Updates & Key Insights

Phio Pharmaceuticals Corp share price today is $1.2, up 3.39%. The stock opened at $1.19 against the previous close of $1.18, with an intraday high of $1.225 and low of $1.1833.

Phio Pharmaceuticals Corp Share Price Chart

Phio Pharmaceuticals Corp

us-stock
To Invest in {{usstockname}}
us-stock

Phio Pharmaceuticals Corp Share Price Performance

$1.2 0.0339(3.39%) PHIO at 23 Mar 2026 02:44 PM Biotechnology
Lowest Today 1.1833
Highest Today 1.225
Today’s Open 1.19
Prev. Close 1.18
52 Week High 3.48
52 Week Low 0.81
Day’s Range: Low 1.1833 High 1.225
52-Week Range: Low 0.81 High 3.48
1 day return -
1 Week return -2.78
1 month return +17.87
3 month return +10.4
6 month return -45.53
1 year return -6.15
3 year return -79.86
5 year return -96.61
10 year return -

Phio Pharmaceuticals Corp Institutional Holdings

Geode Capital Management, LLC 0.80

Vanguard Group Inc 0.75

Fidelity Extended Market Index 0.50

Nomura Healthcare Fund Class I 0.43

Vanguard Institutional Extnd Mkt Idx Tr 0.43

Cetera Investment Advisers 0.37

Susquehanna International Group, LLP 0.17

NT Ext Equity Mkt Idx Fd - L 0.13

Two Sigma Investments LLC 0.12

Fidelity Total Market Index 0.11

Robertson Stephens Wealth Management, LLC 0.09

CapTrust Financial Advisors 0.09

Spartan Extended Market Index Pool F 0.07

NT Ext Equity Mkt Idx Fd - NL 0.07

Fidelity Series Total Market Index 0.07

Spartan Total Market Index Pool G 0.07

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.06

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.05

Morgan Stanley - Brokerage Accounts 0.05

Bank of America Corp 0.01

SBI Securities Co Ltd 0.01

Genworth Financial Wealth Mgmt Inc 0.00

Northern Trust Extended Eq Market Idx 0.00

State St US Extended Mkt Indx NL Cl C 0.00

Activest Wealth Management 0.00

Northern Trust Wilshire 5000 0.00

NT US Market Cap Idx Fd - L 0.00

SSgA U.S. Total Market Index Strategy 0.00

UBS Group AG 0.00

Blackstone Alternative Multi-Strategy I 0.00

BNP Paribas Arbitrage, SA 0.00

Mount Yale Investment Advisors, LLC 0.00

Royal Bank of Canada 0.00

Tower Research Capital LLC 0.00

Virtu Financial LLC 0.00

Phio Pharmaceuticals Corp Market Status

Strong Buy: 0

Buy: 1

Hold: 0

Sell: 0

Strong Sell: 0

Phio Pharmaceuticals Corp Fundamentals

Market Cap 15.79 M

PB Ratio 0.6891

PE Ratio 0.0

Enterprise Value 5.25 M

Total Assets 21.49 M

Volume 257763

Phio Pharmaceuticals Corp Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:4362 0.0M, FY19:21000 0.0M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:4362 0.0M, FY19:21000 0.0M

Annual Net worth FY23:-11662000 -11.7M, FY22:-11305000 -11.3M, FY21:-13212000 -13.2M, FY20:-8794000 -8.8M, FY19:-8841000 -8.8M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:-2000 -0.0M, Q2/2025:-1074000 -1.1M, Q1/2025:null 0.0M, Q3/2024:null 0.0M, Q2/2024:-1000 -0.0M

Quarterly Net worth Q3/2025:-2392000 -2.4M, Q2/2025:-2166000 -2.2M, Q1/2025:-1769000 -1.8M, Q3/2024:-1524000 -1.5M, Q2/2024:-1846000 -1.8M

About Phio Pharmaceuticals Corp & investment objective

Company Information Phio Pharmaceuticals Corp., a clinical stage biopharmaceutical company, engages in the development of immuno-oncology therapeutics in the United States. It develops PH-762, an INTASYL compound designed to reduce the expression of PD-1 in multi-center Phase 1b dose-escalating clinical trials; PH-894, an INTASYL compound that is designed to specifically silence BRD4, a protein that controls gene expression in both T cells and tumor cells in preclinical studies. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Phio Pharmaceuticals Corp. in November 2018. Phio Pharmaceuticals Corp. was founded in 2003 and is based in King Of Prussia, Pennsylvania.

Organisation Biotechnology

Employees 6

Industry Biotechnology

CEO Mr. Robert J. Bitterman

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Phio Pharmaceuticals Corp FAQs

What is the share price of Phio Pharmaceuticals Corp today?

The current share price of Phio Pharmaceuticals Corp is $1.2.

Can I buy Phio Pharmaceuticals Corp shares in India?

Yes, Indian investors can buy Phio Pharmaceuticals Corp shares by opening an international trading and demat account with Motilal Oswal.

How to buy Phio Pharmaceuticals Corp shares in India?

You can easily invest in Phio Pharmaceuticals Corp shares from India by:

Can I buy fractional shares of Phio Pharmaceuticals Corp?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Phio Pharmaceuticals Corp?

Phio Pharmaceuticals Corp has a market cap of $15.79 M.

In which sector does Phio Pharmaceuticals Corp belong?

Phio Pharmaceuticals Corp operates in the Biotechnology sector.

What documents are required to invest in Phio Pharmaceuticals Corp stocks?

To invest, you typically need:

What is the PE and PB ratio of Phio Pharmaceuticals Corp?

The PE ratio of Phio Pharmaceuticals Corp is N/A and the PB ratio is 0.69.